DAFTAR PUSTAKA 1. Kohler. M, Clarenbach. C.F, Brack. T, Russi. E, Bloch. K.

Quality of Life, Physical Disability, and Respiratory Impairment in Duchenne Muscular Dystrophy. Am J Respir Crit Care Med 2005;172, 10321036. 2. Bobo. J.K, Kenneson. A, Kolor. K, Brown. M.A. Adherence to American Academy of Pediatrics Recommendations for Cardiac Care Among Female Carriers of Duchenne and Becker Muscular Dystrophy. Pediatrics 2009; 123:e471e475. 3. Chakkalakal. J, Thompson. J, Parks. R, Jasmin. B. Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J. 2005;19, 880891. 4. Ren. Z, Zhou. C, Xu. Y, Deng. J, Zeng. H, Zeng. H. Mutation and haplotype analysis for Duchenne muscular dystrophy by single cell multiple displacement amplification. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology 2007. 5. McMillan. H, Gregas. M, Darras. B.T, Kang. P.A. Serum Transaminase Levels in Boys With Duchenne and Becker Muscular Dystrophy. Pediatrics 2011;127:e132-e136. 6. Waite A, Tinsley CL, Locke M, Blake DJ. The neurobiology of the dystrophinassociated glycoprotein complex. Ann Med. Jan 26 2009;1-16. 7. Banks GB, Chamberlain JS, Froehner SC. Truncated dystrophins can influence neuromuscular synapse structure. Mol Cell Neurosci. Jan 8 2009. 8. Yanagisawa A, Bouchet C, Quijano-Roy S, Vuillaumier-Barrot S, Clarke N, Odent S, et al. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. Eur J Med Genet. Dec 27 2008. 9. Ngoerah I.G.N.G., 1991; Penyakit Otot; Dalam: Dasar-dasar Ilmu Penyakit Saraf; Airlangga University Press, Surabaya; Hal 227-229. 10. Ropper A.H. & Brow R.H., 2005; Duchenne Muscular Dystrophy (Severe Generalized Muscular Dystrophy of Childhood), In: Adam and Victors

Principles of Neurology, Eight Edition; Mc-Graw Hill, Medical Publishing Division, New York; Page:1214-1217. 11. Mumenthaler M, Mattle H, and Taub E, 2006; Disease of Muscle; In: Fundamentals of Neurology; Thieme; page: 265-267. 12. Goemans, N. M. & Tulinius, M.; Van Den Akker, J. T.; Burm, B. E.; Ekhart, P. F.; Heuvelmans, N.; Holling, T.; Janson, A. A. et al (2011). "Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy". New England Journal of Medicine 364 (16): 15131522. 13. Richardson, M; Frank, A (2009). "Electric powered wheelchairs for those with muscular dystrophy: Problems of posture, pain and deformity". Disability and Rehabilitation: Assistive Technology 4 (3): 181188. 14. Wagner, K; Lechtzin, N; Judge, D (2007). "Current treatment of adult Duchenne muscular dystrophy". Biochimica et Biophysica Acta 1772 (2): 229237.